# | Website | Score in June 2020 | 1m changes |
---|
1 | Anaphylaxis: mechanisms and management | 26 | 0 |
2 | World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy-immunology speciali... | 24 | 0 |
3 | Croup | 19 | 0 |
4 | Acute Bronchiolitis and Croup | 16 | 0 |
5 | Report of the IAU/IAG Working Group on cartographic coordinates and rotational elements: 2006 | 12 | 0 |
6 | Anaphylaxis: Recent advances in assessment and treatment | 12 | 0 |
7 | Understanding the symptoms of the common cold and influenza | 10 | 0 |
8 | Taenia solium cysticercosis | 7 | 0 |
9 | Anaphylaxis: a history with emphasis on food allergy | 7 | 0 |
10 | Pathophysiology of anaphylaxis | 6 | 0 |
11 | Re-evaluation of antibiotic treatment of streptococcal pharyngitis | 6 | 0 |
12 | Chagas disease | 5 | 0 |
13 | Allergy and the cardiovascular system | 5 | 0 |
14 | Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Stud... | 4 | 0 |
15 | American Trypanosomiasis (Chagas Disease) | 4 | 0 |
16 | Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Alle... | 4 | 0 |
17 | History and Classification of Anaphylaxis | 4 | 0 |
18 | Practice Guidelines for the Diagnosis and Management of Group A Streptococcal Pharyngitis | 4 | 0 |
19 | Physical interventions to interrupt or reduce the spread of respiratory viruses | 3 | 0 |
20 | The Economic Burden of Non–Influenza-Related Viral Respiratory Tract Infection in the United States | 3 | 0 |
21 | CROUP | 3 | 0 |
22 | Acute Symptoms of Drug Hypersensitivity (Urticaria, Angioedema, Anaphylaxis, Anaphylactic Shock) | 3 | 0 |
23 | Biphasic anaphylactic reactions | 3 | 0 |
24 | Mosquito-borne Diseases | 2 | 0 |
25 | Zinc for the common cold | 2 | 0 |
26 | Vitamin C for preventing and treating the common cold | 2 | 0 |
27 | Antibiotics for the common cold and acute purulent rhinitis | 2 | 0 |
28 | Echinacea for preventing and treating the common cold | 2 | 0 |
29 | Evolution, molecular epidemiology and perspectives on the research of taeniid parasites with special emphasis on Taenia solium | 2 | 0 |
30 | Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected) | 2 | 0 |
31 | Why is dracunculiasis eradication taking so long? | 2 | 0 |
32 | Schistosomiasis Chemotherapy | 2 | 0 |
33 | Glucocorticoids for croup | 2 | 0 |
34 | Post-mortem diagnosis of anaphylaxis: A difficult task in forensic medicine | 2 | 0 |
35 | Anaphylaxis in the emergency department: a paediatric perspective | 2 | 0 |
36 | Prevalence of Streptococcal Pharyngitis and Streptococcal Carriage in Children: A Meta-analysis | 2 | 0 |
37 | The anatomy of a large-scale hypertextual Web search engine | 1 | 0 |
38 | Web search for a planet: the google cluster architecture | 1 | 0 |
39 | Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study | 1 | 0 |
40 | A new fungal phylum, the Glomeromycota: phylogeny and evolution | 1 | 0 |
41 | A revised six-kingdom system of life | 1 | 0 |
42 | Historia Maritima del Peru. Tomo II. Epoca prehistórica | 1 | 0 |
43 | Historia general del Perú. Jose Antonio Del Busto Duthurburu, general editor. Editorial Brasa, Lima, 1994. 10 vols., figures (vol. 1, 389 figures; vol... | 1 | 0 |
44 | Keys to the Genera and Species of blow Flies (Diptera: Calliphoridae) of America North of Mexico | 1 | 0 |
45 | The Mass of Dwarf Planet Eris | 1 | 0 |
46 | Yellow Fever: A Disease that Has Yet to be Conquered | 1 | 0 |
47 | Estimating and Mapping the Population at Risk of Sleeping Sickness | 1 | 0 |
48 | High-Precision Ephemerides of Planets—EPM and Determination of Some Astronomical Constants | 1 | 0 |
49 | 10.1093/epirev/mxj012 | 1 | 0 |
50 | The common cold | 1 | 0 |
51 | Cough in the Pediatric Population | 1 | 0 |
52 | Sequencing and Analyses of All Known Human Rhinovirus Genomes Reveal Structure and Evolution | 1 | 0 |
53 | Questions and Answers | 1 | 0 |
54 | Sleep Habits and Susceptibility to the Common Cold | 1 | 0 |
55 | Gene studies shed light on rhinovirus diversity | 1 | 0 |
56 | Non-steroidal anti-inflammatory drugs for the common cold | 1 | 0 |
57 | Efficacy and safety of over-the-counter analgesics in the treatment of common cold and flu | 1 | 0 |
58 | Over-the-counter (OTC) medications for acute cough in children and adults in ambulatory settings | 1 | 0 |
59 | Safety and efficacy of over- the-counter cough and cold medicines for use in children | 1 | 0 |
60 | Nasal decongestants for the common cold | 1 | 0 |
61 | Intranasal ipratropium bromide for the common cold | 1 | 0 |
62 | Cough and the Common Cold | 1 | 0 |
63 | Advising patients to increase fluid intake for treating acute respiratory infections | 1 | 0 |
64 | Heated, humidified air for the common cold | 1 | 0 |
65 | Vapor Rub, Petrolatum, and No Treatment for Children With Nocturnal Cough and Cold Symptoms | 1 | 0 |
66 | Honey for acute cough in children | 1 | 0 |
67 | Saline nasal irrigation for acute upper respiratory tract infections | 1 | 0 |
68 | Examining the evidence for the use of vitamin C in the prophylaxis and treatment of the common cold | 1 | 0 |
69 | Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis | 1 | 0 |
70 | Garlic for the common cold | 1 | 0 |
71 | Effect of Vitamin D3Supplementation on Upper Respiratory Tract Infections in Healthy Adults | 1 | 0 |
72 | Interferons and Their Clinical Value | 1 | 0 |
73 | Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges | 1 | 0 |
74 | THE COMMON COLD | 1 | 0 |
75 | Current Consensus Guidelines for Treatment of Neurocysticercosis | 1 | 0 |
76 | Oral vaccines for preventing cholera | 1 | 0 |
77 | Evaluation and Treatment of Chagas Disease in the United States | 1 | 0 |
78 | Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas’ disease | 1 | 0 |
79 | Chagas disease in the 21st Century: a public health success or an emerging threat? | 1 | 0 |
80 | The Tail End of Guinea Worm — Global Eradication without a Drug or a Vaccine | 1 | 0 |
81 | The global burden of neglected tropical diseases | 1 | 0 |
82 | Mumps | 1 | 0 |
83 | BET 4. DOSE OF DEXAMETHASONE IN CROUP | 1 | 0 |
84 | Heliox for croup in children | 1 | 0 |
85 | Anaphylaxis: Office Management and Prevention | 1 | 0 |
86 | Epidemiology of Anaphylaxis | 1 | 0 |
87 | Anaphylaxis and Anesthesia | 1 | 0 |
88 | “Kissing Bugs”: Potential Disease Vectors and Cause of Anaphylaxis | 1 | 0 |
89 | Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatment | 1 | 0 |
90 | Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System | 1 | 0 |
91 | Epidemiology of insect-venom anaphylaxis | 1 | 0 |
92 | Epinephrine and its use in anaphylaxis: current issues | 1 | 0 |
93 | Cardiovascular disease and anaphylaxis | 1 | 0 |
94 | Self-injectable Epinephrine for First-Aid Management of Anaphylaxis | 1 | 0 |
95 | H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review | 1 | 0 |
96 | An update on epidemiology of anaphylaxis in children and adults | 1 | 0 |
97 | Anaphylaxis and insect allergy | 1 | 0 |
98 | Predictors for spread of clinical group A streptococcal tonsillitis within the household | 1 | 0 |
99 | Antibiotic Treatment of Children With Sore Throat | 1 | 0 |
100 | Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin A | 1 | 0 |